[1]
R. RAHMAH, «Government-Use License and Stem Cell-Based Pharmaceuticals Patent: Equitable Access to Covid-19 Medications»,
Utopía y prax. latinoam.
, vol. 25, n.º 1, pp. 94-110, sep. 2020.